Nitrosomonas eutropha D23 clinical trials
Also written B244.
How each study uses nitrosomonas eutropha D23 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the nitrosomonas eutropha D23 studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Development codes
- B244
- 8
Studies by the year they started
10 studies that test it; most in 2018 (4)
| Year | Studies |
|---|---|
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 4 |
| 2020 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 10 · Other 0
AOBiome LLC (10)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1
Studies that test nitrosomonas eutropha D23.
Studies
Open first, then newest update. How each study uses nitrosomonas eutropha D23 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 10
- Study to Determine Efficacy, Safety, and Tolerability of B244 as a Topical Spray in Subjects With Moderate to Severe Acne VulgarisNot yet recruitingPhase 2AOBiome LLCNCT07866105Written as B244
- B244 Topical Spray for the Treatment of Pruritus in Adults With a History of Atopic DermatitisCompletedPhase 2AOBiome LLCNCT04490109Written as B244
- A Study of B244 Delivered as a Topical Spray to Assess Safety in Pediatric Subjects With Atopic DermatitisCompletedPhase 1AOBiome LLCNCT03775434Written as Experimental: B244
- Study to Assess the Safety, Tolerability, and Preliminary Efficacy of B244 in Healthy Volunteers and Subjects With Seasonal Allergic RhinitisCompletedPhase 1/2AOBiome LLCNCT03290248Written as B244 suspension
- Study to Determine Safety and Efficacy of B244 in Subjects With Mild to Moderate Atopic DermatitisCompletedPhase 2AOBiome LLCNCT03235024Written as B244
- Study to Determine Safety and Efficacy of B244 in Subjects With Episodic MigraineCompletedPhase 2AOBiome LLCNCT03488563Written as B244
- A Study to Determine Safety and Efficacy of B244 in Subjects With Mild to Moderate RosaceaCompletedPhase 2AOBiome LLCNCT03590366Written as B244
- Clinical Trial in Subjects With Mild to Moderate Acne VulgarisCompletedPhase 2/3AOBiome LLCNCT02832063Written as B244
- A Prospective Study of B244 Delivered as a Topical Spray to Determine Safety and Efficacy in Subjects With Elevated Blood PressureCompletedPhase 2AOBiome LLCNCT02998840Written as B244
- A Double Blind, Placebo-Controlled, Randomized Study in Subjects With Acne VulgarisCompletedPhase 1/2AOBiome LLCNCT02656485Written as B244